Status:
NOT_YET_RECRUITING
Different Oral Iron Dosing Regimens in Treatment of Iron Deficency Anemia in Patients With Chronic Kidney Disease
Lead Sponsor:
Assiut University
Conditions:
CKD
Eligibility:
All Genders
18+ years
Brief Summary
Comparing between the efficacy of alternate day oral iron dose, once daily and thrice daily dose in improving anemia in CKD patients
Detailed Description
Anemia is common in chronic kidney disease (CKD) and has been associated with impaired quality of life, cardiovascular disease (CVD) and mortality. Iron deficiency is common in patients with CKD and ...
Eligibility Criteria
Inclusion
- All adult patients above 18 years old with CKD stages 2,3 and 4
Exclusion
- CKD stage 5 (eGFR below 15 ).
- Patients with hemolytic anemias.
- Chronic liver diseases .
- Autoimmune diseases.
- Malignancy
- History of blood transfusion last 3 months before the study
- Pregnancy
- Adult polycystic kidney disease ( APCKD)
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06521216
Start Date
August 1 2024
End Date
August 1 2025
Last Update
July 25 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.